The effect of the administration of propranolol 0.15 mg per kg body weight i.v. on the metabolic response to pelvic surgery was compared with results in similar patients who had not received propranolol. The only significant difference between the two groups was a lower plasma insulin concentration in the betablockade patients after 60 and 90 min of surgery. The glycaemic response to surgery was unimpaired in the propranolol-treated patients and there were no adverse haemodynamic effects. We conclude that padrenergic blockade is unlikely to have deleterious metabolic effects in healthy patients.
Propranolol was introduced into clinical practice in 1965 and since then P-adrenergic blocking drugs have been used with increasing frequency for the treatment of hypertension, angina and hyperthyroidism. For many years it was recommended that p-blocking drugs be discontinued before surgery, but recently Prys-Roberts and colleagues (1973) and Kopriva, Brown and Pappas (1978) have questioned the necessity and desirability of this policy. It is now common to find patients maintained on P-blocking drugs up to the time of surgery. Most of the studies on the interactions of (^-blockade and anaesthesia have concentrated on the haemodynamic and myocardial effects. Since there have been several reports of hypoglycaemia associated with propranolol treatment (Kotler, Berman and Rubenstein, 1966; Mackintosh, 1967; Skinner and Misbin, 1976) , we have investigated the metabolic effects of padrenergic blockade in patients undergoing gynaecological surgery.
PATIENTS AND METHODS
Twenty-four healthy women, admitted for Fallopian tube surgery, were investigated. They were allocated randomly to receive either propranolol 0.15 mg per kg body weight i.v. or an equivalent volume of saline. The nature of the study and the potential risks were explained to all patients before consent was obtained. The study was approved by the ethics committee of Hammersmith Hospital.
All patients were premedicated with papaveretum 15-20 mg and hyoscine 0.3-0.4 mg i.m. 1 h before surgery. On arrival in the anaesthetic room the duration of starvation before operation was determined and a central venous catheter was inserted percutaneously from an antecubital fossa to permit blood sampling and the administration of i.v. fluids and drugs. After the patient had rested for 15 min a control blood sample was collected and heart rate, arterial pressure and aural temperature measured. The calculated dose of propranolol, or an equivalent volume of 0.9% saline solution, was injected i.v. Fifteen minutes later another blood sample was collected and the physiological measurements repeated.
Anaesthesia was induced with sufficient thiopentone to abolish the eyelash reflex, the trachea was intubated following the administration of pancuronium and the lungs were ventilated with nitrous oxide in oxygen supplemented with 0.5% halothane using a Cape-Waine ventilator with a semi-closed circuit incorporating soda-lime. Ventilation was adjusted to maintain an end-tidal carbon dioxide concentration of 4.0-4.5% (Hartmann Braun URAS 4 infra-red carbon dioxide analyser) and an inspired oxygen concentration of 35-40% (Servomex DCL 101 Mk II oxygen analyser). The operating room temperature was maintained at 24 °C. Physiological saline solution was administered i.v. during surgery at approximately 6 ml kg" 1 h" 1 . Blood transfusion was not required as the measured blood loss did not exceed 150 ml.
Blood samples were collected at 30-min intervals during surgery and were analysed for glucose, glycerol, free fatty acids (FFA), lactate and alanine by methods described previously (Hall et al., 1980) and for insulin by radioimmunoassay using a human standard (WHO 66/304). The concentrations of each metabolite and insulin were estimated in duplicate and the coefficients of variation were: glucose 0.9%, glycerol 1.0%, FFA 1.2%, alanine 1.7%, lactate 3.8%, insulin 4.5%. At the same time as the blood sample was obtained the heart rate, arterial pressure and aural temperature were recorded .
On the 3rd day after operation the skinfold thicknesses of the patient were measured using skin calipers (John Bull, British Indicators Ltd) according to the method of Durnin and Rahaman (1974) , and the percentage of fat to body weight calculated.
The results are expressed as mean values (± SEM). A two-way analysis of variance was used in both groups of patients to determine the presence of a significant change in mean concentration of substrate or hormone with time. A hierarchical two-way analysis of variance was performed, to assess the significance of any difference between the mean values of each group.
RESULTS
Details of the patients are shown in table I. The propranolol-treated patients were significantly fatter than the saline group (P<0.05). The changes in heart rate, mean arterial pressure and aural temperature are shown in table II. In the saline group of patients there was a significant increase in heart rate after 30 min of surgery (P<0.01) but this was not maintained during the remainder of the operation. The administration of propranolol was associated with a marked decrease in heart rate from 87 to 59 beat min" 1 before surgery (P < 0.01). The onset of surgery caused an increase in heart rate in the propranolol-treated patients but the rates remained significantly less than the control value for the duration of surgery (P<0.05 and <0.01). Comparison between the two groups showed that there was a significantly slower heart rate in the p"-blocked patients 15 min after the administration of propranolol and after 30 min of surgery (P<0.05), but thereafter the differences were not significant. Mean arterial pressure decreased slightly in both groups of patients, but this change was not significant. Aural temperature decreased significantly after 30 min of surgery in both groups (P<0.01) and this persisted for the duration of the study.
Changes in the concentrations of the metabolites and insulin are shown in table III. Both groups of patients showed the typical glycaemic response to surgery with an increase in blood glucose concentration from 3.94 to 5.08 mmol litre"' in the saline group (P<0.01) and from 4.09 to 6.06 mmol litre ~J in the propranolol-treated patients (P<0.01). Plasma insulin values did not change significantly in the saline group, but were significantly decreased during surgery in the P-blocked patients (P<0.01). There was a significant difference between the insulin concentrations of the groups after 60 and 90 min of surgery (P<0.05). Blood lactate concentrations increased during surgery to 1.10 mmol litre" 1 (P<0.01) in the saline group and to 1.11 mmol litre" 1 (P<0.05) in the propranolol group. Plasma FFA and glycerol concentrations did not change significantly in the saline-treated patients, but in the p-blocked patients there were significant decreases in glycerol (P<0.05) and FFA (P<0.01 and <0.05) after 30 and 60 min of surgery. Blood alanine concentrations did not change significantly during this study.
DISCUSSION
The most important finding of this study was that P-adrenergic blockade had no adverse effects on the metabolic changes found during surgery. In particular the glycaemic response was normal and there was no evidence of hypoglycaemia in spite of 15 h starvation before operation. This is reassuring, as the cardiovascular response to hypoglycaemia is altered by propranolol with the occurrence of a bradycardia and hypertension (LloydMostyn and Oram, 1975) , thus making hypoglycaemia even more difficult to detect under anaesthesia. One of the problems in assessing the metabolic effects of P-adrenergic blockade is the difficulty in quantifying the degree of blockade. The most common method is the construction of doseresponse curves to isoprenaline with and without the P-adrenergic blocking drug (Vaughan Williams, Bagwell and Singh, 1973 ), but we considered this inappropriate in the present study both on ethical grounds and because of the effects of isoprenaline on metabolism. The administration i.v. of propranolol 0.15 mg kg"' caused a marked decrease in heart rate from 87 to 59 beat min ~' after 15 min, but the rate increased when surgery began (table III) . It is possible that this was a result of inadequate adrenergic blockade, but this is unlikely as the half-life of propranolol i.v. is 2-3.8 h (Shand, 1976) . The most likely explanation for the increase in heart rate during surgery in propranolol-treated patients is the withdrawal of parasympathetic tone (Higgins, Vatner and Braunwald, 1973) . Niarchos, Tahmooressi and Tarazi (1978) demonstrated that propranolol 10 mg i.v. abolished the isoprenalineinduced increase in heart rate but had only a limited effect on the tachycardia produced by changes in posture and the inhalation of amyl nitrate. Our results confirm the findings of Kopriva, Brown and Pappas (1978) that the heart rate response to surgery in patients anaesthetized with halothane is not a useful guide to the adequacy of P-adrenergic blockade, and suggest that the routine use of atropine in such patients, as advocated by Prys-Roberts and colleagues (1973) , is unnecessary.
i
The failure of insulin secretion during surgery in the presence of an increased blood glucose concentration is well known (table III) and is thought to be the result of an increase in sympathetic activity in which a-adrenergic effects producing inhibition of insulin secretion predominate over the P-stimulatory effects (Allison, 1971) . It is not surprising, therefore, that in the presence of propranolol the a-adrenergic inhibitory effects were even more pronounced with significantly lower plasma insulin concentrations after 60 and 90 min of surgery (P<0.05) (table  III) . The lower plasma insulin values in the propranolol-treated patients were associated with a small increase in blood glucose concentration compared with the saline group. Basal insulin concentrations were not changed significantly by P-blockade, confirming the findings of other workers (Porte, 1967; Cerasi, Luft and Efendic, 1972; Robertson and Porte, 1973) . Day (1975) suggested that an important mechanism in the production of hypoglycaemia during P-adrenergic blockade was a decrease in the availability of gluconeogenic precursors. However, we failed to find any difference in the concentrations of three key gluconeogenic substrates, alanine, lactate and glycerol, between the two groups of patients (table III) . The only gluconeogenic precursor to show an increase during surgery was lactate. We have observed a small but statistically significant increase in blood lactate concentration during surgery in other studies (Hall et al., 1978; Cooper et al., 1979) and the possible cause of this slight lacticacidaemia has been discussed previously . It is probable, therefore, that hepatic glycogenolysis rather xhan gluconeogenesis makes the greater contribution to the increase in blood glucose concentration found during pelvic surgery. This may explain the failure of propranolol to affect the glycaemic response (table III) as the balance of the evidence suggests that catecholamine-mediated hepatic glycogenolysis occurs via stimulation of the aadrenoreceptors (Syvalahti et al., 1977) .
Many studies have demonstrated that Pblockade produces a significant decrease in plasma FFA values in various stressful states (for review see Day, 1975) . Although the propanolol-treated patients had a significant reduction in plasma FFA and glycerol concentrations after 30 and 60 min of surgery, there was not a significant difference between the two groups of patients (table III) . It is important to note, however, that the patients given propanolol were more obese than the saline group (P < 0.05, table I). Jung and colleagues (1979) have shown recently not only that obese subjects have higher basal FFA values than normal subjects but also that the lipolytic response to noradrenaline is greater in the obese. On this basis the patients in the P-blocked group have a greater adrenergicallymediated lipolytic response to surgery than the saline group and thus the effect of propranolol on plasma FFA and glycerol concentrations shown in table III is underestimated. This emphasizes the necessity of determining accurately the obesity of patients participating in metabolic studies.
In many patients, for example those with hypertension and coronary artery disease, there are haemodynamic benefits in maintaining Padrenergic blockade up to the time of surgery and the results of the present study indicate that there are unlikely to be any severe metabolic problems. It must be emphasized, however, that we investigated young healthy women and it is unwise to extrapolate these findings to patients with < abnormalities of glucose production and utilization, particularly diabetics, young children and septicaemic patients.
BLOCAGE BETA-ADRENERGIQUE ET LA REPONSE METABOLIQUE EN CHIRURGIE

RESUME
On compare l'effet de 1'administration de 0,15 mg par kilo de poids corporel de propranolol i.v. sur la rcponse metabolique a la chirurgie pelvique chez des patients analogues ayant ou non rccu du propranolol. La seule difference marquee entre les deux groupes consistait en une concentration d'insuline dans le plasma plus basse chez les patients soumis au blocage beta 60 et 90 min aprcs Popcration. La reponse glycemique a la chirurgie ne fut pas alteree chez les patients ayant recoi un traitement beta-propranolol et on n'observa aucun effet hemodynamique adverse. On en tire la conclusion que le blocage betaadrenergique ne produit vraisemblablement aucun effct metabolique nodf chez des patients sains. 
